196 related articles for article (PubMed ID: 12731628)
21. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia.
Inagi K; Ford CN; Bless DM; Heisey D
J Voice; 1996 Sep; 10(3):306-13. PubMed ID: 8865102
[TBL] [Abstract][Full Text] [Related]
22. Laryngeal long latency response conditioning in abductor spasmodic dysphonia.
Deleyiannis FW; Gillespie M; Bielamowicz S; Yamashita T; Ludlow CL
Ann Otol Rhinol Laryngol; 1999 Jun; 108(6):612-9. PubMed ID: 10378532
[TBL] [Abstract][Full Text] [Related]
23. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
Ford CN; Bless DM; Lowery JD
Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
[TBL] [Abstract][Full Text] [Related]
24. Abnormalities in long latency responses to superior laryngeal nerve stimulation in adductor spasmodic dysphonia.
Ludlow CL; Schulz GM; Yamashita T; Deleyiannis FW
Ann Otol Rhinol Laryngol; 1995 Dec; 104(12):928-35. PubMed ID: 7492063
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection.
Ludlow CL; Naunton RF; Terada S; Anderson BJ
Otolaryngol Head Neck Surg; 1991 Jun; 104(6):849-55. PubMed ID: 1908979
[TBL] [Abstract][Full Text] [Related]
26. Botulinum toxin for spasmodic dysphonia.
Rodriquez AA
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036
[TBL] [Abstract][Full Text] [Related]
27. Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.
Cannito MP; Kahane JC; Chorna L
Clin Interv Aging; 2008; 3(1):131-51. PubMed ID: 18488884
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up of recurrent laryngeal nerve avulsion for the treatment of spastic dysphonia.
Weed DT; Jewett BS; Rainey C; Zealear DL; Stone RE; Ossoff RH; Netterville JL
Ann Otol Rhinol Laryngol; 1996 Aug; 105(8):592-601. PubMed ID: 8712628
[TBL] [Abstract][Full Text] [Related]
29. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture.
Crevier-Buchman L; Laccourreye O; Papon JF; Nurit D; Brasnu D
J Voice; 1997 Jun; 11(2):232-7. PubMed ID: 9181547
[TBL] [Abstract][Full Text] [Related]
30. Laryngeal electromyography in movement disorders: preliminary data.
Kimaid PA; Quagliato EM; Crespo AN; Wolf A; Viana MA; Resende LA
Arq Neuropsiquiatr; 2004 Sep; 62(3A):741-4. PubMed ID: 15334243
[TBL] [Abstract][Full Text] [Related]
31. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
Boutsen F; Cannito MP; Taylor M; Bender B
J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
33. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
[TBL] [Abstract][Full Text] [Related]
34. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series.
Blitzer A
Eur J Neurol; 2010 Jul; 17 Suppl 1():28-30. PubMed ID: 20590805
[TBL] [Abstract][Full Text] [Related]
35. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
Brin MF; Blitzer A; Fahn S; Gould W; Lovelace RE
Mov Disord; 1989; 4(4):287-96. PubMed ID: 2811888
[TBL] [Abstract][Full Text] [Related]
36. Technique for injection of botulinum toxin through the flexible nasolaryngoscope.
Rhew K; Fiedler DA; Ludlow CL
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):787-94. PubMed ID: 7991260
[TBL] [Abstract][Full Text] [Related]
37. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
Casserly P; Timon C
J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
[TBL] [Abstract][Full Text] [Related]
38. Effects of botulinum toxin type A injections on aerodynamic measures of spasmodic dysphonia.
Adams SG; Durkin LC; Irish JC; Wong DL; Hunt EJ
Laryngoscope; 1996 Mar; 106(3 Pt 1):296-300. PubMed ID: 8614192
[TBL] [Abstract][Full Text] [Related]
39. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
Holzer SE; Ludlow CL
Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
[TBL] [Abstract][Full Text] [Related]
40. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
